Clinical Trials Browser

Phase 1/2 × Terminated × Pluvicto × Clear all

NCT03545165 2021-08-24

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Phase 1/2 Terminated

6 enrolled 24 charts

Prostatic Neoplasms